
Testing a Hypothesis: Poor Sleep Could Be an Early Warning Sign or Biomarker of Alzheimer's
Yasmin Anwar

Andrew Stevovich, Woman With Autumn Leaves, 1994, 36" x 72", oil. Private Collection. Wikimedia Commons
Sleep may be a missing piece in the Alzheimer's disease puzzle.
UC Berkeley scientists have found compelling evidence that poor sleep — particularly a deficit of the deep, restorative slumber needed to hit the save button on memories — is a channel through which the beta-amyloid protein believed to trigger Alzheimer's disease attacks the brain’s long-term memory.
"Our findings reveal a new pathway through which Alzheimer's disease may cause memory decline later in life," said UC Berkeley neuroscience professor Matthew Walker, senior author of the study published today in the journal Nature Neuroscience.
Excessive deposits of beta-amyloid are key suspects in the pathology of Alzheimer's disease, a virulent form of dementia caused by the gradual death of brain cells. An unprecedented wave of aging baby boomers is expected to make Alzheimer's disease, which has been diagnosed in more than 40 million people, one of the world's fastest-growing and most debilitating public health concerns.
The good news about the findings, Walker said, is that poor sleep is potentially treatable and can be enhanced through exercise, behavioral therapy and even electrical stimulation that amplifies brain waves during sleep, a technology that has been used successfully in young adults to increase their overnight memory.
"This discovery offers hope," Walker said. "Sleep could be a novel therapeutic target for fighting back against memory impairment in older adults and even those with dementia."
The study was co-led by UC Berkeley neuroscientists Bryce Mander and William Jagust, a leading expert on Alzheimer's disease. The team has received a major National Institutes of Health grant to conduct a longitudinal study to test their hypothesis that sleep is an early warning sign or biomarker of Alzheimer’s disease.

While most research in this area has depended on animal subjects, this latest study has the advantage of human subjects recruited by Jagust, a professor with joint appointments at UC Berkeley's Helen Wills Neuroscience Institute, the School of Public Health and Lawrence Berkeley National Laboratory.
Pages: 1 · 2
More Articles
- A Yale Medicine Doctor Explains How Naloxone, a Medication That Reverses an Opioid Overdose, Works
- Statement by Anthony S. Fauci, M.D.: Inspiring and Mentoring the Next Generation of Scientific Leaders As They Help Prepare the World to Face Future Infectious Disease Threats
- Kaiser Health News Research Roundup: Pan-Coronavirus Vaccine; Long Covid; Supplemental Vitamin D; Cell Movement
- How They Did It: Tampa Bay Times Reporters Expose High Airborne Lead Levels at Florida Recycling Factory
- On A Chilly Saturday, Winter Graduates Turn to Their Future: “Some of (your) most important lessons came from a real-life curriculum no one ever anticipated”
- Julia Sneden Wrote: Puzzling: Jumbled Words, Anagrams, Crosswords, Cryptograms, Acrostics, I Love Them All
- A Scout Report Selection: Science-Based Medicine
- Journalist's Resource: Religious Exemptions and Required Vaccines; Examining the Research
- Government of Canada Renews Investment in Largest Canadian Study on Aging
- Kaiser Health News: Paying Billions for Controversial Alzheimer’s Drug? How About Funding This Instead?